We have recently reported on the
major upcoming changes for pharmaceutical patent owners in
accordance with the 4th amendment of the patent law
which establishes a patent linkage system and patent term
extensions (PTEs) in China.
Now a further step has been taken by the responsible authority
to establish the necessary Drug Patent Information Record Platform.
On May 18 the Center for Drug Evaluation ("CDE") of the
National Medical Products Administration ("NMPA") made a
trial version available. The database in trial version can be
evaluated until May 31. It is accessible here.
While this is a preliminary version and opened for public
comments first, it can be expected that the final database will not
be much different. Further details can be found below.
